Linear release nanoparticle devices for advanced targeted cancer therapies with increased efficacy

The cross-linked supramolecular structure of prepared polyester based nanoparticles enable increased and efficient small molecule drug loading after nanoparticle formation and post-modification with targeting peptides via thiol-ene ‘click’ chemistry. It could be demonstrated that the drug loading does not influence the structural integrity of the particle and its diameter was not significantly changed. A prolonged linear release profile of the drug without the typical ‘burst effect’ was observed in emulsified particles and mirrored the linear degradation profile of the investigated particles, which are critical properties for controlled and predictable pharmacokinetics in cancer therapies. Furthermore, the final peptide-targeted and drug-loaded particles were found to be readily dispersed in buffer or water, and with the confirmed biocompatibility, these novel and adjustable drug delivery systems are promising vectors for the treatment of various cancers.

[1]  D. Hallahan,et al.  Determining glioma response to radiation therapy using recombinant peptides , 2008, Expert review of anticancer therapy.

[2]  A. Lamprecht,et al.  Effect of the microencapsulation of nanoparticles on the reduction of burst release. , 2007, International journal of pharmaceutics.

[3]  Robert Langer,et al.  PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. , 2009, Biomaterials.

[4]  M. Gulisano,et al.  Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity , 2008, BMC Cancer.

[5]  E. Harth,et al.  Approach to formation of multifunctional polyester particles in controlled nanoscopic dimensions. , 2008, Journal of the American Chemical Society.

[6]  K. Shakesheff,et al.  Polymeric systems for controlled drug release. , 1999, Chemical reviews.

[7]  S. Feng,et al.  Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Milan Makale,et al.  Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis , 2008, Proceedings of the National Academy of Sciences.

[9]  Robert Langer,et al.  Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. , 2007, Biomaterials.

[10]  U. Bakowsky,et al.  Preparation and characterization of cationic PLGA nanospheres as DNA carriers. , 2004, Biomaterials.

[11]  S. Chien,et al.  Chemotherapeutic engineering : Vitamin E TPGS-emulsified nanoparticles of biodegradable polymers realized sustainable paclitaxel chemotherapy for 168h in vivo , 2007 .

[12]  D. Hallahan,et al.  Noninvasive assessment of cancer response to therapy , 2008, Nature Medicine.

[13]  E. Harth,et al.  Tailored polyester nanoparticles: post-modification with dendritic transporter and targeting units via reductive amination and thiol-ene chemistry , 2009 .